Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2025-12-27 @ 10:11 PM
Study NCT ID:
NCT01381861
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2011-06-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Sponsor:
Tracon Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07
Start Date Type:
None
Primary Completion Date:
2012-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-12
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-21
First Submit QC Date:
None
Study First Post Date:
2011-06-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-11-15
Results First Submit QC Date:
None
Results First Post Date:
2019-03-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-28
Last Update Post Date:
2019-03-05
Last Update Post Date Type:
ACTUAL